Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2009
06/18/2009US20090155335 Non-leaching non-fouling antimicrobial coatings
06/18/2009US20090155312 Viral variants detection and application
06/18/2009US20090155305 Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant
06/18/2009US20090155304 Modified Cyanovirin-N Polypeptide
06/18/2009US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
06/18/2009US20090155298 Matrix Metalloproteinase 11 Vaccine
06/18/2009US20090155297 Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
06/18/2009US20090155295 Vaccine
06/18/2009US20090155294 Hcv vaccines
06/18/2009US20090155293 Modified defensins and their use
06/18/2009US20090155286 Type I interferon blocking agents for prevention and treatment of psoriasis
06/18/2009US20090155279 Pseudomonas Aeruginosa Outer Membrane Protein PA5158
06/18/2009US20090155277 Use of immunesuppressant receptor
06/18/2009US20090155271 pro-inflammatory cytokines, interleukins (IL-17A, IL-17F)
06/18/2009US20090155270 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza
06/18/2009US20090155268 Growth Factor Binding Constructs Materials and Methods
06/18/2009US20090155267 Molecule and chimeric molecules thereof
06/18/2009US20090155264 Novel composition and methods for the treatment of psoriasis
06/18/2009US20090155263 Compositions and methods for the treatment of immune related diseases
06/18/2009US20090155258 Peptide-based passive immunization therapy for treatment of atherosclerosis
06/18/2009US20090155246 Antibodies Specific For Soluble Amyloid Beta Peptide Protofibrils and Uses Thereof
06/18/2009US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
06/18/2009US20090155239 Novel Protease, Microorganism Producing the Same, and Application Thereof
06/18/2009US20090155234 Detection of mutations in a gene associated with resistance to viral infection, mx1
06/18/2009US20090155231 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery
06/18/2009US20090155213 Lactobacillus acidophilus nucleic acids and uses thereof
06/18/2009US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
06/18/2009US20090155170 Annexin derivatives suitable for pretargeting in therapy and diagnosis
06/18/2009US20090155166 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
06/18/2009US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives
06/18/2009DE102007059891A1 C-terminale lfapsoriasinfragmente als antimikrobielle Peptide, deren Herstellung und Verwendung C-terminal lfapsoriasinfragmente as antimicrobial peptides, their preparation and use
06/18/2009DE102005009784B4 Peptid-Mimetika, Verfahren zur deren Herstellung, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung als Inhibitoren von Proteasomen und zur Induktion von Apoptose Peptide mimetics, methods for their preparation, pharmaceutical composition containing them and their use as inhibitors of proteasomes and inducing apoptosis
06/18/2009CA2708719A1 High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
06/18/2009CA2708260A1 Improved immunizing composition
06/18/2009CA2708134A1 Cyclic protein free from cysteines
06/18/2009CA2707979A1 Polypeptides modified by protein trans-splicing technology
06/18/2009CA2707850A1 Reverse protein
06/18/2009CA2707735A1 Sarp-1 fusion proteins and uses thereof
06/18/2009CA2707733A1 Advantageous salts of mu-opiate receptor peptides
06/18/2009CA2707132A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques
06/17/2009EP2071338A2 Human diabetes-mediating proteins
06/17/2009EP2071335A2 Detection of auto-antibodies from patients suffering from rheumatoid arthritis
06/17/2009EP2071040A2 Diagnostics and therapeutics for vascular disease
06/17/2009EP2071028A2 HLA-DR-binding antigen peptide derived from WT1
06/17/2009EP2070949A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
06/17/2009EP2070946A2 Invention affecting GLP-1 and Exendin
06/17/2009EP2070945A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae
06/17/2009EP2070944A1 Specific binding agents of human angiopoietin-2
06/17/2009EP2070546A1 Preventives/remedies for cancer
06/17/2009EP2070542A2 Method of extended culture of antigen-specific cyotoxic T lymphocytes
06/17/2009EP2069792A1 Method and kit for detecting if an individual is susceptible to progress to an active mycobacterial disease
06/17/2009EP2069509A2 Plants having enhanced yield-related traits and a method for making the same
06/17/2009EP2069508A2 Plants having enhanced yield-related traits and a method for making the same
06/17/2009EP2069504A1 Plants having enhanced seed yield-related traits and a method for making the same
06/17/2009EP2069502A1 Method for making maturated insulin polypeptides
06/17/2009EP2069484A1 Influenza b viruses having alterations in the hemaglutinin polypeptide
06/17/2009EP2069473A2 Antibiotic antimicrobial agents and methods of their use
06/17/2009EP2069399A2 Interferons of rhesus and cynomolgus origin and uses thereof
06/17/2009EP2069398A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells
06/17/2009EP2069397A1 Crystal structures of both isoforms of human glutamic acid decarboxylase
06/17/2009EP2069396A2 Modified human plasma polypeptide or fc scaffolds and their uses
06/17/2009EP2069395A1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
06/17/2009EP2069394A1 Identification of candidate vaccine antigens from dichelobacter nodosus
06/17/2009EP2069393A2 Avian influenza vaccine
06/17/2009EP2069392A2 Tnf superfamily fusion proteins
06/17/2009EP2069390A2 Opsin stabilizing compounds and methods of use
06/17/2009EP2069389A2 Glucanases, nucleic acids encoding them and methods for making and using them
06/17/2009EP2069388A2 Peptides derived from the c2 domain of epsilon pkc, and use thereof
06/17/2009EP2069384A2 Biomarker fragments for the detection of human bnp
06/17/2009EP2069376A2 Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
06/17/2009EP2068935A1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
06/17/2009EP2068909A2 Modified fgf-21 polypeptides and their uses
06/17/2009EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use
06/17/2009EP2068889A1 Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
06/17/2009EP2068887A2 Sp35 antibodies and uses thereof
06/17/2009EP2068622A2 Method and mixture for in-vivo photochemical cross-linking of collagen
06/17/2009EP1948679A4 Method for preparing recombinant peptide from spider venom and analgesic composition containing the peptide
06/17/2009EP1943263A4 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors
06/17/2009EP1790654B1 Peptide capable of binding to insulin-binding protein and adsorbent
06/17/2009EP1780215B1 Crohn's disease antibody epitope peptide and reagent for testing crohn's disease
06/17/2009EP1745078B1 Method for the purification of albumin conjugates
06/17/2009EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds
06/17/2009EP1716228A4 System and method of up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the appplication of fields generated by specific and selective electric and electromagnetic signals
06/17/2009EP1648933B1 Long lasting insulin derivatives and methods thereof
06/17/2009EP1611238B1 Glutamate transport modulatory compounds and methods
06/17/2009EP1409544B1 Human dr4 antibodies and uses thereof
06/17/2009EP1390408A4 A molecular marker
06/17/2009EP1315802B1 Phenol oxidizing enzyme variants
06/17/2009EP1179003B1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
06/17/2009EP1177304B1 Modified factor viia polypeptides
06/17/2009EP1165765B1 Arabidopsis thaliana derived frigida gene conferring late flowering
06/17/2009EP1140131B1 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
06/17/2009EP1124590B1 Enzyme-mediated modification of fibrin for tissue engineering
06/17/2009EP1015496B1 Divalent anti-t cells immunotoxins and use thereof
06/17/2009CN101460517A Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (FPP)
06/17/2009CN101456911A Erythrocyte-stimulating factor mimic peptide derivative, medical salts thereof, preparation method and use thereof
06/17/2009CN101456910A Wood frog antibiotic peptides and preparation technology and its application in antiviral drug
06/17/2009CN101456909A Soja bean HKT protein and coding gene thereof and application
06/17/2009CN101456908A Transcription factor protein and coding gene thereof and application
06/17/2009CN101456907A Plant source anti gray mold protein and use thereof